Shasun Pharmaceuticals Ltd(Merged)
Next 500 2015
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#160(2015)
#160(2015)
Financial Data 2015
Revenue
1,339
(INR Cr)
Net Operating Income
1,317
(INR Cr)
Assets
1,124
(INR Cr)
Profit
24
(INR Cr)
Net Worth
379
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1339 6.8% | 1253 11.6% | 1124 1.3% | 1110 25.8% | 882 9.2% | 808 5.5% | 766 - |
| Net Operating Income (INR Cr) | 1317 8.57% | 1213 11.79% | 1085 1.72% | 1066 27.80% | 834 6.42% | 784 4.43% | 751 -7.19% |
| Profit (INR Cr) | 24 -21.4% | 30 -43.0% | 53 -47.3% | 101 277.8% | 27 606.1% | 4 - | -137 - |
| Assets (INR Cr) | 1124 12.5% | 1000 27.6% | 783 34.9% | 581 35.4% | 429 -3.5% | 444 -0.1% | 445 - |
| Net Worth (INR Cr) | 379 25.2% | 303 11.2% | 272 22.4% | 222 164.9% | 84 -28.8% | 118 10.8% | 106 -55.6% |
| Employee Cost (INR Cr) | 236 9.3% | 216 15.9% | 187 17.1% | 159 11.3% | 143 2.2% | 140 -18.5% | 172 - |
| Interest Cost (INR Cr) | 63 | 50 | 32 | 44 | 32 | 30 | 22 |
| Cash & Bank Balance (INR Cr) | 3 | 13 | 6 | 14 | 12 | 15 | 8 |
| Total Debt (INR Cr) | 739 | 692 | 506 | 353 | 329 | 327 | 339 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 1.8% | 2.4% | 4.7% | 9.1% | 3.0% | 0.5% | - |
| Profit As % Of Assets | 2.1% | 3.0% | 6.8% | 17.3% | 6.2% | 0.9% | - |
| Profit As % Of Networth | 6.3% | 10.0% | 19.5% | 45.2% | 31.7% | 3.2% | - |
| Interest Cost to EBITDA % | 54.3% | 45.6% | 27.5% | 35.5% | 45.1% | 98.2% | - |
| Debt to Equity Ratio | 1.95 | 2.29 | 1.86 | 1.59 | 3.92 | 2.77 | 3.18 |
| RONW | 5.9% | 10.5% | 21.5% | 46.4% | 25.5% | -10.5% | - |
| ROCE | 7.9% | 8.2% | 12.1% | 18.8% | 12.7% | 3.3% | -25.3% |